Terms: = Ovarian cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR
11 results:
1. RTN2, a new member of circadian clock genes identified by database mining and bioinformatics prediction, is highly expressed in ovarian cancer.
Zheng X; Lv X; Chai J; Huang Y; Zhu L; Zhang X
Mol Med Rep; 2022 Nov; 26(5):. PubMed ID: 36177918
[TBL] [Abstract] [Full Text] [Related]
2. cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers.
Fonnes T; Telle IO; Forsse D; Falck R; Trovik J; Haldorsen IS; Krakstad C
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():25-31. PubMed ID: 33161211
[TBL] [Abstract] [Full Text] [Related]
3. Having co-morbid cardiovascular disease at time of cancer diagnosis: already one step behind when it comes to HRQoL?
Schoormans D; Husson O; Oerlemans S; Ezendam N; Mols F
Acta Oncol; 2019 Dec; 58(12):1684-1691. PubMed ID: 31389275
[No Abstract] [Full Text] [Related]
4. Development of predictive models to identify advanced-stage cancer patients in a US healthcare claims database.
Esposito DB; Russo L; Oksen D; Yin R; Desai VCA; Lyons JG; Verpillat P; Peñalvo JL; Lamy FX; Lanes S
Cancer Epidemiol; 2019 Aug; 61():30-37. PubMed ID: 31128428
[TBL] [Abstract] [Full Text] [Related]
5. LGR5 receptor promotes cell-cell adhesion in stem cells and colon cancer cells via the IQGAP1-Rac1 pathway.
Carmon KS; Gong X; Yi J; Wu L; Thomas A; Moore CM; Masuho I; Timson DJ; Martemyanov KA; Liu QJ
J Biol Chem; 2017 Sep; 292(36):14989-15001. PubMed ID: 28739799
[TBL] [Abstract] [Full Text] [Related]
6. Gliomatosis peritonei: a particular entity with specific outcomes within the growing teratoma syndrome.
Bentivegna E; Gonthier C; Uzan C; Genestie C; Duvillard P; Morice P; Gouy S
Int J Gynecol Cancer; 2015 Feb; 25(2):244-9. PubMed ID: 25594144
[TBL] [Abstract] [Full Text] [Related]
7. Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer.
Kumar J; Fraser FW; Riley C; Ahmed N; McCulloch DR; Ward AC
Br J Cancer; 2014 Jan; 110(1):133-45. PubMed ID: 24220695
[TBL] [Abstract] [Full Text] [Related]
8. Prostate-specific antigen velocity and prostate cancer gleason grade and stage.
Pinsky PF; Andriole G; Crawford ED; Chia D; Kramer BS; Grubb R; Greenlee R; Gohagan JK
Cancer; 2007 Apr; 109(8):1689-95. PubMed ID: 17330856
[TBL] [Abstract] [Full Text] [Related]
9. Laparoscopic findings during adnexal surgery in women with a history of nongynecologic malignancy.
Juretzka MM; Crawford CL; Lee C; Wilton A; Schuman S; Chi DS; Sonoda Y; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2006 May; 101(2):327-30. PubMed ID: 16360202
[TBL] [Abstract] [Full Text] [Related]
10. Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas.
Savarese TM; Mitchell K; McQuain C; Campbell CL; Guardiani R; Wuu J; Ollari C; Reale F; Nelson BE; Chen A; Quesenberry PJ
Cancer Lett; 2001 Jan; 162(1):105-15. PubMed ID: 11121868
[TBL] [Abstract] [Full Text] [Related]
11. The current status of ultrasound and color Doppler imaging in screening for ovarian cancer.
Karlan BY; Platt LD
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S28-33. PubMed ID: 7835806
[TBL] [Abstract] [Full Text] [Related]
